Atlas Trials

Study of DP303c Injection in Patients With Advanced Ovarian Cancer

Clinical trial NCT04828616 · UNKNOWN

Trial details

NCT number
NCT04828616
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2021-07-01
Primary completion
2023-07-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.